Skip to main content
Sankar Swaminathan
( out of 12 reviews )

Sankar Swaminathan, MD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Infectious Diseases, Area E
50 N Medical Dr
Salt Lake City , UT 84132

Sankar Swaminathan, MD has specialized expertise in the treatment of infectious diseases. He is board certified in Internal Medicine and Infectious Diseases. His main clinical focus is in the diagnosis and treatment of infections in immunocompromised patients, including cancer patients and transplant recipients. He has integrated a research program funded by the National Cancer institute on the role of viruses in cancers into his clinical practice.

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine (Sub: Infectious Disease)

Patient Rating

5.0 /5
( out of 12 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Apr 30, 2026
UNIVERSITY HOSPITAL

Couldn't be happier with the care I received from Dr. Swaminathan. He explained everything well and made time to see me when I was in town (I live in Montana).

Dec 14, 2025
UNIVERSITY HOSPITAL

He was very thorough and showed a real Personal interest. His expertise was very evident. Utah is lucky to have hem here.


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Sankar Swaminathan, MD has specialized expertise in the treatment of infectious diseases. He is board certified in Internal Medicine and Infectious Diseases. His main clinical focus is in the diagnosis and treatment of infections in immunocompromised patients, including cancer patients and transplant recipients. He has integrated a research program funded by the National Cancer institute on the role of viruses in cancers into his clinical practice.

Board Certification and Academic Information

Academic Departments Pathology -Adjunct Professor
Internal Medicine -Professor
Academic Divisions Infectious Diseases
Board Certification
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Infectious Disease)

Education history

Undergraduate Biochemistry and Molecular Biology, magna cum laude - Harvard College A.B.
Professional Medical Medicine - Emory University School of Medicine M.D.
Graduate Training Microbiology and Immunology - Emory University School of Medicine M.S.
Internship Internal Medicine - University of Chicago Medical Center Intern
Residency Internal Medicine - University of Chicago Medical Center Resident
Fellowship Infectious Disease - Beth Israel Hospital, Brigham & Women's Hospital, Dana Farber Cancer Institute Clinical Fellow
Fellowship Medicine - Harvard Medical School Clinical Fellow
Research Fellow Infectious Disease - Beth Israel Hospital, Brigham & Women's Hospital, Dana Farber Cancer Institute Research Fellow
Research Fellow Microbiology and Molecular Genetics - Harvard Medical School Research Fellow

Selected Publications

Journal Article

  1. Li D, Mosbruger T, Verma D, Swaminathan (2020). Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription. Journal of virology, 94(2),
  2. Verma D, Church TM, Swaminathan (2020). Epstein-Barr virus co-opts TFIIH component XPB to specifically activate essential viral lytic promoters. Proceedings of the National Academy of Sciences of the United States of America, 117(23), 13044-13055.
  3. Harmon KG, Pottinger PS, Baggish AL, Drezner JA, Luks AM, Thompson AA, Swaminathan (2020). Comorbid Medical Conditions in Young Athletes: Considerations for Preparticipation Guidance During the COVID-19 Pandemic. Sports health, 12(5), 456-458.
  4. Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, Andes DR, Chandrasekar P, Galdys AL, Hanson KE, Marr KA, Mayer J, Mehta S, Morris MI, Perfect J, Revankar SG, Smith B, Swaminathan S, Thompson GR, Varghese M, Vazquez J, Whimbey E, Wingard JR, Nguyen M (2019). How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers. Clinical infectious diseases, 68(5), 850-853.
  5. Fu W, Verma D, Burton A, Swaminathan (2019). Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication. Journal of virology, 93(4),
  6. Li D, Swaminathan (2019). Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system. PLoS pathogens, 15(2), e1007609.
  7. Agrawal R, Durupt G, Verma D, Montgomery M, Vieira-de Abreu A, Taylor C, Swaminathan S, Fisher S (2019). MicroRNA-7a overexpression in VMH restores the sympathoadrenal response to hypoglycemia. JCI insight, 4(20),
  8. Church TM, Verma D, Thompson J, Swaminathan (2018). Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV. Journal of virology, 92(6),
  9. Li D, Fu W, Swaminathan (2018). Continuous DNA replication is required for late gene transcription and maintenance of replication compartments in gammaherpesviruses. PLoS pathogens, 14(5), e1007070.
  10. Baglio SR, van Eijndhoven MA, Koppers-Lalic D, Berenguer J, Lougheed SM, Gibbs S, Léveillé N, Rinkel RN, Hopmans ES, Swaminathan S, Verkuijlen SA, Scheffer GL, van Kuppeveld FJ, de Gruijl TD, Bultink IE, Jordanova ES, Hackenberg M, Piersma SR, Knol JC, Voskuyl AE, Wurdinger T, Jiménez CR, Middeldorp JM, Pegtel D (2016). Sensing of latent EBV infection through exosomal transfer of 5'pppRNA. Proceedings of the National Academy of Sciences of the United States of America, 113(5), E587-96.
  11. Verma D, Thompson J, Swaminathan (2016). Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function. Proceedings of the National Academy of Sciences of the United States of America, 113(13), 3609-14.
  12. Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith (2016). Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 14(7), 882-913.
  13. Verma D, Li DJ, Krueger B, Renne R, Swaminathan (2015). Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein. Journal of virology, 89(3), 1688-702.
  14. Thompson J, Verma D, Li D, Mosbruger T, Swaminathan (2015). Identification and Characterization of the Physiological Gene Targets of the Essential Lytic Replicative Epstein-Barr Virus SM Protein. Journal of virology, 90(3), 1206-21.
  15. Li DJ, Verma D, Mosbruger T, Swaminathan (2014). CTCF and Rad21 act as host cell restriction factors for Kaposi's sarcoma-associated herpesvirus (KSHV) lytic replication by modulating viral gene transcription. PLoS pathogens, 10(1), e1003880.

Case Report

  1. Swaminathan P, Swaminathan (2020). Nail Findings in Chikungunya Infection. Open forum infectious diseases, 7(2), ofaa031.

Letter

  1. Swaminathan S, Schlaberg R, Lewis J, Hanson KE, Couturier M (2016). Fatal Zika Virus Infection with Secondary Nonsexual Transmission. The New England journal of medicine, 375(19), 1907-1909.